MalariaGEN is a global malaria research network with partners in 20 countries, including Africa, Asia, Europe and North America. The aim of MalariaGEN is to bring together expert scientists to explore and identify critical mechanisms of protective immunity against malaria which could lead to successful malaria vaccine development.
This data provider is associated with 5 studies:
|EGAS00000000026||MalariaGEN case-control study in the Gambia|
|EGAS00000000087||Genome wide association study of severe malaria in Gambian mother-father-child trios|
|EGAS00000000088||Genome wide association study of severe malaria in Ghanain mother-farther-child trios|
|EGAS00001000807||Imputation-Based Meta-Analysis of Severe Malaria in Three African Populations|
|EGAS00001001311||Genome wide study of resistance to severe malaria in eleven worldwide populations|